Sarcoma  >>  Tevimbra (tislelizumab-jsgr)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tevimbra (tislelizumab-jsgr) / BeiGene
UMBRELLA, NCT06332274: tislelizUMaB in canceR Patients With molEcuLar residuaL Disease

Not yet recruiting
3
717
Europe
Tislelizumab, Blood sampling, Placebo
Gustave Roussy, Cancer Campus, Grand Paris, BeiGene, C2i Genomics
Cancer, Lung Cancer, Colo-rectal Cancer, Pancreas Cancer, Soft Tissue Sarcoma
05/28
04/29

Download Options